These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21488305)

  • 41. Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia.
    Haider S; Islam B; D'Atri V; Sgobba M; Poojari C; Sun L; Yuen T; Zaidi M; New MI
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2605-10. PubMed ID: 23359706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.
    Barbat B; Bogyo A; Raux-Demay MC; Kuttenn F; Boué J; Simon-Bouy B; Serre JL; Mornet E
    Hum Mutat; 1995; 5(2):126-30. PubMed ID: 7749410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene symbol: CYP17A1. Disease: Steroid 17-alpha-hydrolylase deficiency.
    Patocs AP; Liko I; Racz K
    Hum Genet; 2005 May; 116(6):539. PubMed ID: 15991317
    [No Abstract]   [Full Text] [Related]  

  • 44. [Mutational spectrum of the gene for 21-hydroxylase in the patients with congenital adrenal hyperplasia from Bashkortostan].
    Akhmetova VL; Ramova ZF; Malievskiĭ OA; Khusnutdinova EK
    Genetika; 2008 Oct; 44(10):1420-8. PubMed ID: 19062540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia.
    Tsai LP; Cheng CF; Hsieh JP; Teng MS; Lee HH
    Clin Chim Acta; 2009 Dec; 410(1-2):48-53. PubMed ID: 19778530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comment on congenital adrenal hyperplasia without demonstrable genetic mutations.
    White PC
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2976-7. PubMed ID: 10443708
    [No Abstract]   [Full Text] [Related]  

  • 47. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P.
    Lee HH; Tsai FJ; Lee YJ; Yang YC
    Mol Genet Metab; 2006 Aug; 88(4):372-7. PubMed ID: 16684614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect.
    Loidi L; Quinteiro C; Parajes S; Barreiro J; Lestón DG; Cabezas-Agrícola JM; Sueiro AM; Araujo-Vilar D; Catro-Feijóo L; Costas J; Pombo M; Domínguez F
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):330-6. PubMed ID: 16487445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mutation analysis in families with 21-hydroxylase deficiency].
    Wang H; Jiang L; Wang PP; Zhou HB; Wang JL; Song LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):681-4. PubMed ID: 18067083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First case of V281+I172N/V281L CYP21A2 genotype associated with congenital adrenal hyperplasia form. A case report from South Italy.
    Concolino P; Corsello S; Carrozza C; Minucci A; Santonocito C; Lovicu RM; Santini SA; Ameglio F; Zuppi C; Capoluongo E
    Clin Biochem; 2007 Dec; 40(18):1435-6. PubMed ID: 18028896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency.
    Billerbeck AE; Bachega TA; Frazatto ET; Nishi MY; Goldberg AC; Marin ML; Madureira G; Monte O; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2870-2. PubMed ID: 10443693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
    Wedell A
    Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monozygotic twins with congenital adrenal hyperplasia: long-term endocrine evaluation and gene analysis.
    AvRuskin TW; Witchel SF; Taha DR; Juan CS
    J Pediatr Endocrinol Metab; 2003; 16(4):565-70. PubMed ID: 12793610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiplex ligation-dependent probe amplification analysis is useful for diagnosing congenital adrenal hyperplasia but requires a deep knowledge of CYP21A2 genetics.
    Concolino P; Mello E; Minucci A; Zuppi C; Capoluongo E
    Clin Chem; 2011 Jul; 57(7):1079-80. PubMed ID: 21507910
    [No Abstract]   [Full Text] [Related]  

  • 55. A 42-year-old man presented with adrenal incidentaloma due to non-classic congenital adrenal hyperplasia with a novel CYP21A2 mutation.
    Falhammar H; Torpy DJ
    Intern Med J; 2016 Sep; 46(9):1115-6. PubMed ID: 27633475
    [No Abstract]   [Full Text] [Related]  

  • 56. Secondary amenorrhoea associated with high serum 17-hydroxyprogesterone levels revealing a heterozygous CYP21A2 mutation in a woman with Addison disease.
    Boscolo M; Bry-Gauillard H; Tardy V; Young J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):620-2. PubMed ID: 25353971
    [No Abstract]   [Full Text] [Related]  

  • 57. An approach to the molecular biology of congenital adrenal hyperplasia.
    Chung BC; Matteson KJ; Morin JE; Mellon SH; Miller WL
    Ann N Y Acad Sci; 1985; 458():238-51. PubMed ID: 3879125
    [No Abstract]   [Full Text] [Related]  

  • 58. Steroidogenesis and CYP enzymes.
    Luft FC
    J Mol Med (Berl); 2001 Oct; 79(10):549-50. PubMed ID: 11692151
    [No Abstract]   [Full Text] [Related]  

  • 59. Heterozygous POR gene mutations in a patient with congenital adrenal hyperplasia.
    Gusmano C; Calogero AE; Cannarella R
    Endocrine; 2022 Aug; 77(2):401-402. PubMed ID: 35635658
    [No Abstract]   [Full Text] [Related]  

  • 60. Late onset adrenal hyperplasia: mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitous.
    Wells G; Azziz R
    Fertil Steril; 1990 Nov; 54(5):819-23. PubMed ID: 2226916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.